ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,334Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 3734

$1.48M Total Retail Price of All Prescriptions

Rank: 19 out of 3734

790 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 790 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 790 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 21,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 1,141 990 1 3
FUROSEMIDE 1,038 837 2 7
SIMVASTATIN 978 899 3 1
OMEPRAZOLE 902 704 4 4
AMLODIPINE BESYLATE 786 693 5 5
LEVOTHYROXINE SODIUM 774 656 6 2
METOPROLOL TARTRATE 692 531 7 6
ATENOLOL 656 558 8 13
HYDROCHLOROTHIAZIDE 586 465 9 9
CITALOPRAM HBR 487 428 10 16
JANTOVEN 484 450 11 76
SERTRALINE HCL 477 357 12 18
RISPERIDONE 379 244 13 62
WARFARIN SODIUM 369 224 14 10
METFORMIN HCL 367 305 15 8
DONEPEZIL HCL 366 351 16 25
GABAPENTIN 340 257 17 17
POLYETHYLENE GLYCOL 3350 333 220 18 53
LOVASTATIN 315 266 19 41
POTASSIUM CHLORIDE 313 230 20 19
BACLOFEN 285 82 21 142
MIRTAZAPINE 283 231 22 45
ATORVASTATIN CALCIUM 281 222 23 11
TRAZODONE HCL 273 213 24 49
RANITIDINE HCL 252 148 25 32
ALENDRONATE SODIUM 249 207 26 26
DIVALPROEX SODIUM 229 186 27 99
GLIPIZIDE 223 208 28 57
TRAMADOL HCL 222 177 29 20
LANTUS 221 173 30 54
IPRATROPIUM-ALBUTEROL 215 137 31 98
PAROXETINE HCL 201 145 32 59
HUMALOG 193 162 33 146
QUETIAPINE FUMARATE 191 120 34 82
ESCITALOPRAM OXALATE 189 97 35 68
TAMSULOSIN HCL 188 134 36 29
LAMOTRIGINE 188 59 36 169
DIGOXIN 181 162 38 43
ISOSORBIDE MONONITRATE ER 180 159 39 34
NAMENDA 177 165 40 44
HYDROCODONE-ACETAMINOPHEN 172 131 S3 41 12
METOPROLOL SUCCINATE 164 162 42 14
FLUTICASONE PROPIONATE 156 95 43 46
LEVETIRACETAM 148 93 44 105
VENLAFAXINE HCL ER 146 59 45 84
CLOPIDOGREL 142 125 46 23
LACTULOSE 137 67 47 137
OXYBUTYNIN CHLORIDE 130 93 48 151
OLANZAPINE 128 86 49 106
FLUOXETINE HCL 124 68 50 61
OXYCODONE HCL 124 88 S2 50 58
ALLOPURINOL 124 118 50 33
NOVOLIN N 123 91 53 295
SPIRIVA 123 86 53 40
NOVOLOG 122 107 55 112
DILANTIN 120 74 56 254
ABILIFY 119 68 57 159
PREDNISONE 118 107 58 42
FAMOTIDINE 117 90 59 60
KLOR-CON M20 116 116 60 48
FENTANYL 116 87 S2 60 65
HYDRALAZINE HCL 115 107 62 111
PRAVASTATIN SODIUM 115 101 62 15
METOCLOPRAMIDE HCL 111 12 64 158
BENZTROPINE MESYLATE 110 70 R 65 173
SODIUM CHLORIDE 109 0 66 268
AMITRIPTYLINE HCL 107 87 R 67 94
ADVAIR DISKUS 106 78 68 35
PLAVIX 104 92 69 39
AZITHROMYCIN 103 85 70 38
NYSTATIN-TRIAMCINOLONE 102 100 71 200
OXYBUTYNIN CHLORIDE ER 98 60 72 141
CARVEDILOL 98 91 72 30
NITROFURANTOIN 97 18 74 227
LIPITOR 97 60 74 90
FINASTERIDE 96 70 76 88
CARBAMAZEPINE 93 11 77 172
PANTOPRAZOLE SODIUM 92 66 78 22
PROAIR HFA 90 70 79 83
GLYBURIDE 89 89 R 80 64
TRAVATAN Z 88 77 81 278
CARBIDOPA-LEVODOPA 88 88 81 92
SINGULAIR 85 41 83 95
QUINAPRIL HCL 85 72 83 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 64 85 117
CRESTOR 83 80 85 28
DOXAZOSIN MESYLATE 83 48 85 100
VENLAFAXINE HCL 82 62 88 213
FLOVENT HFA 81 56 89 199
EXELON 80 80 90 150
OXYCODONE-ACETAMINOPHEN 80 51 S2 90 51
TRIAMCINOLONE ACETONIDE 76 60 92 131
DETROL LA 76 24 92 153
SPIRONOLACTONE 75 48 94 80
PHENYTOIN SODIUM EXTENDED 75 46 94 149
HUMULIN N 73 57 96 324
LOSARTAN POTASSIUM 72 72 97 21
LYRICA 72 37 97 124
PHENYTOIN 71 39 99 288
HALOPERIDOL 71 49 99 212
OXYCONTIN 70 58 S2 101 121
LEXAPRO 70 40 101 236
SYNTHROID 69 60 103 47
CIPROFLOXACIN HCL 69 51 103 77
SEROQUEL 68 34 105 161
NYSTATIN 68 59 105 162
ENALAPRIL MALEATE 68 55 105 63
NEXIUM 67 0 108 36
CLONIDINE HCL 66 25 109 79
CYMBALTA 65 54 110 67
DIVALPROEX SODIUM ER 65 15 110 198
DILTIAZEM 24HR CD 65 56 110 97
GEMFIBROZIL 63 45 113 114
VALPROIC ACID 63 0 113 223
METHENAMINE HIPPURATE 62 39 115 523
LEVOFLOXACIN 61 53 116 116
NYSTOP 60 52 117 187
ZOLPIDEM TARTRATE 58 51 118 24
LANTUS SOLOSTAR 58 50 118 102
VERAPAMIL ER 57 57 120 96
LUMIGAN 56 47 121 451
LEVEMIR 55 43 122 202
GLIPIZIDE ER 55 30 122 119
BUSPIRONE HCL 54 38 124 129
ADVAIR HFA 54 35 124 458
CEPHALEXIN 53 31 126 120
CARAFATE 52 25 127 331
LIDODERM 51 15 128 170
INSULIN SYRINGE 50 38 129 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.